World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
129
Citations
68271
World Ranking
2572
National Ranking
267

Overview

David E. Neal is affiliated with the University of Cambridge in the United Kingdom. Their research primarily focuses on the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with notable contributions in subfields such as Pulmonary and Respiratory Medicine, Genetics, Oncology, Molecular Biology, and Surgery.

The scientist's work covers several key topics, including:

  • Prostate Cancer Treatment and Research
  • Prostate Cancer Diagnosis and Treatment
  • Genetic Associations and Epidemiology
  • Colorectal Cancer Screening and Detection
  • Bladder and Urothelial Cancer Treatments
  • Global Cancer Incidence and Screening
  • Health Systems, Economic Evaluations, Quality of Life

Frequent co-authors collaborating with David E. Neal include:

  • Freddie C. Hamdy
  • Jenny Donovan
  • Richard M. Martin
  • Johanna Schleutker
  • Rosalind A. Eeles

Common publication venues where their research appears are:

  • The Prostate
  • bioRxiv (Cold Spring Harbor Laboratory)
  • UNC Libraries
  • Nature Genetics
  • Nature Communications

Some recent papers authored or co-authored by David E. Neal include:

  • Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer, 2023, New England Journal of Medicine
  • Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction, 2021, Nature Genetics
  • An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk, 2020, Nature Communications
  • Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants, 2023, Nature Genetics
  • Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen, 2020, Cancer Causes & Control

Best Publications

  • Pan-cancer analysis of whole genomes

    Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

  • 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer

    Freddie C. Hamdy;Jenny L. Donovan;J. Athene Lane;Malcolm Mason

  • The evolutionary history of lethal metastatic prostate cancer.

    Gunes Gundem;Peter Van Loo;Peter Van Loo;Peter Van Loo;Barbara Kremeyer;Ludmil B. Alexandrov

  • Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer

    Donovan Jl;Hamdy Fc;Lane Ja;Mason M

  • CD133, a novel marker for human prostatic epithelial stem cells

    Gavin D. Richardson;Craig N. Robson;Shona H. Lang;David E. Neal

  • Multiple newly identified loci associated with prostate cancer susceptibility.

    Rosalind A Eeles;Rosalind A Eeles;Zsofia Kote-Jarai;Graham G Giles;Graham G Giles;Ali Amin Al Olama

  • Patterns of somatic structural variation in human cancer genomes

    Yilong Li;Nicola D Roberts;Jeremiah A Wala;Jeremiah A Wala;Ofer Shapira;Ofer Shapira

  • Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

    Fredrick R. Schumacher;Ali Amin Al Olama;Sonja I. Berndt;Sara Benlloch

  • Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours.

    DavidE. Neal;DavidE. Neal;MarkK. Bennett;MarkK. Bennett;ReginaldR. Hall;ReginaldR. Hall;Colin Marsh;Colin Marsh

  • Quality improvement report: Improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study. Commentary: presenting unbiased information to patients can be difficult.

    Jenny Donovan;Nicola Mills;Monica Smith;Lucy Brindle

  • Upregulation and Nuclear Recruitment of HDAC1 in Hormone Refractory Prostate Cancer

    Kalipso Halkidou;Luke Gaughan;Susan Cook;Hing Y. Leung

  • The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis

    Charles E Massie;Andy Lynch;Antonio Ramos-Montoya;Joan Boren

  • Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array

    Rosalind A. Eeles;Ali Amin Al Olama;Sara Benlloch;Edward J. Saunders

  • Levels of Matrix Metalloproteases in Bladder Cancer Correlate with Tumor Grade and Invasion

    Bernard Davies;Jonathan Waxman;Harpret Wasan;Paul Abel

  • A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice.

    M.H. Khadra;R.S. Pickard;M. Charlton;P.H. Powell

  • A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer

    Ali Amin Al Olama;Zsofia Kote-Jarai;Sonja I. Berndt;David V. Conti

  • Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers.

    Shinya Hayami;John D. Kelly;Hyun Soo Cho;Masanori Yoshimatsu

  • Spatial genomic heterogeneity within localized, multifocal prostate cancer

    Paul C. Boutros;Paul C. Boutros;Michael Fraser;Nicholas J. Harding;Richard De Borja

  • Identification and isolation of human prostate epithelial stem cells based on α2β1-integrin expression

    Anne T. Collins;Fouad K. Habib;Norman J. Maitland;David E. Neal

  • The evolutionary history of lethal metastatic prostate cancer

    G Gundem;P Van Loo;B Kremeyer;L B Alexandrov

Frequent Co-Authors

Freddie C. Hamdy
Freddie C. Hamdy University of Oxford
Jenny L Donovan
Jenny L Donovan University of Bristol
Richard M. Martin
Richard M. Martin University of Bristol
Rosalind A. Eeles
Rosalind A. Eeles Institute of Cancer Research
Graham G. Giles
Graham G. Giles University of Melbourne
Kenneth W. Muir
Kenneth W. Muir University of Manchester
Zsofia Kote-Jarai
Zsofia Kote-Jarai Institute of Cancer Research
Ian G. Mills
Ian G. Mills University of Oxford
Johanna Schleutker
Johanna Schleutker Turku University Hospital
Lisa A. Cannon-Albright
Lisa A. Cannon-Albright University of Utah

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering a medical career but want more flexible study options, numerous online degrees can set you on the right path. Nursing continues to be a leading choice, thanks to a growing demand for qualified professionals and a variety of online pathways that suit different educational backgrounds.

For those starting out, online nursing courses can provide essential foundations and prepare you for further study or entry-level roles in healthcare. Licensed nurses who wish to expand their qualifications and advance in their careers may consider accredited rn to bsn online programs for enhanced job opportunities.

If your aim is to practice at an advanced level, explore the cheapest online nurse practitioner programs, which combine affordability with recognized credentials. Those interested in research, education, or leadership roles can opt for an online nursing doctorate, opening doors to the highest levels of professional practice.

These online degrees and pathways allow students to balance their studies with other commitments, making medical education in the USA more accessible than ever.

Best Scientists Citing David E. Neal

Trending Scientists

Recently Published Articles